Health authorities in Galicia reported on 13 August 2026 that the project Xenoma Galicia had identified 42 people in 2,504 samples analysed who carry genetic variants that increase the risk of serious inherited conditions. The figures come from statements by the Consellería de Sanidade and the Fundación Pública Galega de Medicina Xenómica .
According to this information, 22 of the 42 cases involve variants associated with hereditary breast and ovarian cancer ; seven findings relate to Lynch syndrome; twelve were classified as familial hypercholesterolaemia . One person had two of the risk profiles listed. The analysis includes 1,037 blood samples from a pilot project, 796 samples from a pilot project using saliva, and 671 samples from the ongoing Phase 1 survey.
Xenoma Galicia is a genomic screening and research initiative run by the Xunta de Galicia under the umbrella of the Consellería de Sanidade, with scientific leadership from the Fundación Pública Galega de Medicina Xenómica and the participation of the Servizo Galego de Saúde. On 23 February 2026, the regional government announced a new phase in which a further 5,000 blood samples are to be analysed across several areas of healthcare. The aim is to identify known disease-related variants in the population, so that people affected can be referred early for specialist assessment and preventive options can be considered.
According to the authorities, participation is voluntary and by invitation; positive findings are communicated individually to participants, who are referred to the relevant specialist clinics. The figures now available are presented as an interim update on the pilot and early phases.
Based on the information currently available, it remains unclear how positive cases are distributed demographically (for example, by age, sex or place of residence), what procedures and timescales apply to genetic counselling and follow-up tests, and what capacity the clinics will need. The latest announcements contain no aggregated figures on these points. No figures have yet been published on follow-up examinations already arranged or initial clinical outcomes.
Context: The reported findings suggest that, during its start-up phase, Xenoma Galicia has identified a small but medically relevant proportion of people carrying risk variants. The effects on care pathways, preventive services and resources within the Servizo Galego de Saúde will depend on the results of later, expanded project phases and their implementation in clinical practice.
Editor: Mira Cadena (Article created with AI assistance).